Definium Therapeutics (DFTX) Non Operating Investment Income (2025 - 2026)
Definium Therapeutics' (DFTX) quarterly Non Operating Investment Income came in at -$262000.0 in Q1 2026, down 2720.0% year-on-year from $10000.0 in Q1 2025, and down 397.73% on a QoQ basis from $88000.0 in Q4 2025.
Definium Therapeutics (DFTX) Non Operating Investment Income (2025 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 2 years of Non Operating Investment Income data on file, last reported at -$262000.0 in Q1 2026.
- On a quarterly basis, Non Operating Investment Income fell 2720.0% year-over-year to -$262000.0 in Q1 2026; TTM through Mar 2026 was $58000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $330000.0, changed N/A from the prior year.
- Non Operating Investment Income for Q1 2026 stood at -$262000.0, down from $88000.0 in the prior quarter.
- Over the last five years, Non Operating Investment Income for DFTX reached as high as $196000.0 in Q3 2025 and fell as low as -$262000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Definium Therapeutics | 4.71 Bn | 4.71 Bn | - | -262,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -262,000.00 |
| Mar 31, 2026 | -262,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |